abstract |
Disclosed are substituted benzo[d]isoxazol-3-yl amine compounds of general formula (I), which are suitable for the treatment of pain while being provided with an excellent affinity to the KCNQ2/3 K+ channel and thus being suitable for the treatment of disorders or diseases that are transmitted at least in part through KCNQ2/3 K+ channels. |